Ticker
LYELCompany Name
LYELL IMMUNOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Net Cash Flow - Investment Acquisitions and Disposals |
---|---|
6/30/2025 | $ 169.4M |
3/31/2025 | $ 201.92M |
12/31/2024 | $ 154.23M |
9/30/2024 | $ -31.33M |
6/30/2024 | $ 66.56M |
3/31/2024 | $ 175.07M |
12/31/2023 | $ 186.73M |
9/30/2023 | $ 338.63M |
6/30/2023 | $ 184.47M |
3/31/2023 | $ 62.81M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Minimum
Mar 31, 2022
Maximum
Sep 30, 2023
Average
Median
filtered constituents | 2.5K |
---|---|
min | $ -9.71M |
max | $ 9.69M |
average | $ 36.68K |
median | $ 0 |
std | $ 2.27M |